Share on

Understanding Velcade® (bortezomib) for Injection

Velcade® (bortezomib) is a proteasome inhibitor that plays a role throughout the myeloma disease course, from induction therapy for the newly diagnosed, to a possible role as part of conditioning for stem cell transplant, to consolidation/maintenance therapy, to treatment for those whose myeloma has relapsed or become refractory

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.